A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis(SAR).
Clinical trial NCT06315426 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06315426
- Sponsor
- Genrix (Shanghai) Biopharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-24
- Primary completion
- 2025-05-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.